Analystreport

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was upgraded by analysts at Credit Suisse Group AG from a "neutral" rating to an "outperform" rating.

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations